Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy

INTRODUCTION: Celiac disease (CeD) diagnosis has worldwide shared protocols. Conversely, follow-up of patients is still an object of study. Gluten immunogenic peptide detection in the urine (GIP) appears to be a new and efficient method for dietary gluten control of patients. The present study aims...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciacci, Carolina, Gagliardi, Mario, Siniscalchi, Monica, Ruotolo, Monica, Santonicola, Antonella, Hajji, Najla, Zingone, Fabiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605791/
https://www.ncbi.nlm.nih.gov/pubmed/34815686
http://dx.doi.org/10.2147/CEG.S326137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605791/
https://www.ncbi.nlm.nih.gov/pubmed/34815686
http://dx.doi.org/10.2147/CEG.S326137

Ejemplares similares